Showing results (631-640 of 1,296) with videos related to
Sort By:
Pageof 130
Nature Reviews. Drug Discovery|January 18, 2022
Immune targets for therapeutic development in depression: towards precision medicineWayne C Drevets, Gayle M Wittenberg, Edward T Bullmore, et al.Nature Reviews. Drug Discovery|January 19, 2022
PROTAC targeted protein degraders: the past is prologueMiklós Békés, David R Langley, Craig M CrewsNature Reviews. Drug Discovery|March 1, 2014
Drugging the p53 pathway: understanding the route to clinical efficacyKian Hoe Khoo, Khoo Kian Hoe, Chandra S Verma, et al.Nature Reviews. Drug Discovery|October 1, 2011
Integrating predictive biomarkers and classifiers into oncology clinical development programmesRobert A Beckman, Jason Clark, Cong ChenNature Reviews. Drug Discovery|October 1, 2011
The influence of the 'organizational factor' on compound quality in drug discoveryPaul D Leeson, Stephen A St-GallayNature Reviews. Drug Discovery|February 2, 2012
(Mis)treating the pharmacogenetic incidentalomeIsaac S KohaneNature Reviews. Drug Discovery|March 31, 2012
Defining rewardable innovation in drug therapyJeffrey K Aronson, Robin E Ferner, Dyfrig A HughesNature Reviews. Drug Discovery|March 31, 2012
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyondP Mark Hogarth, Geoffrey A PieterszNature Reviews. Drug Discovery|April 2, 2011
Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?Shankar Balasubramanian, Laurence H Hurley, Stephen NeidleNature Reviews. Drug Discovery|August 2, 2011
The impact of mergers on pharmaceutical R&DJohn L LaMattinaPageof 130